Drug Patents owned by Mylan

1. Drug name - EVOCLIN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7374747 MYLAN Pharmaceutical foam Jan, 2024

(1 year, 3 months from now)

US7141237 MYLAN Pharmaceutical foam Feb, 2024

(1 year, 3 months from now)

Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient

Treatment: Treatment of acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
1% AEROSOL, FOAM;TOPICAL Prescription

2. Drug name - OLUX E

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8962000 MYLAN Microemulsion and sub-micron emulsion process and compositions Aug, 2025

(2 years from now)

US8460641 MYLAN Microemulsion process and composition Nov, 2028

(6 years from now)

Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Treatment: Treatment of corticosteroid-responsive dermatoses

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.05% AEROSOL, FOAM;TOPICAL Prescription

3. Drug name - VUSION

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8147852 MYLAN Modified azole compounds as antifungal and antibacterial agents Mar, 2028

(5 years from now)

Drugs and Companies using MICONAZOLE NITRATE; PETROLATUM, WHITE; ZINC OXIDE ingredient

Treatment: Use for treatment of diaper dermatitis complicated by candidiasis

Dosage: OINTMENT;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.25%;81.35%;15% OINTMENT;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.